A Molecular Profile of Colorectal Cancer to Guide Therapy [PDCCEs]

GSE41568

Homo sapiens

132 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

The ability to dissect heterogeneity in colorectal cancer (CRC) is a critical step in developing predictive biomarkers. The goal of this study was to develop a gene expression based molecular subgrouping model, which predicts the likelihood that patients will respond to specific therapies.

PubMed ID

28060954

Publication Title

Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.

Total Samples

133

Submitter’s Institution

Duke University

Authors

Lu M, Zessin AS, Glover W, Hsu DS

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-41568

No rows found